Wed.Aug 17, 2022

article thumbnail

Top 5 Tips On How To Run Successful Meetings As A Pharmacist

IDStewardship

In this article tips for running successful meetings as a pharmacist are provided and discussed. . Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 21 August 2022. Meetings are a part of life in the professional world, particularly for pharmacists that work in administrative, clinical, or industry positions. This includes having internal pharmacy department meetings as well as coordinating inter-professional institutional meetings such as a Pharmacy and Therapeutics Commit

article thumbnail

Addressing Language Barriers, Medication Therapy Management at Medicare Part D Outreach Clinics

Pharmacy Times

Rajul A. Patel, PharmD, PhD, director of the Medicare Part D Outreach Clinics at the University of the Pacific in Stockton, California, discusses his work providing drug savings advice to Medicare beneficiaries in diverse communities.

139
139
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MHRA approves Pluvicto® and Locametz® for prostate cancer

European Pharmaceutical Review

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation for Pluvicto ® (lutetium [ 177 Lu] vipivotide tetraxetan), for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy or who are not medically suitable for taxanes.

article thumbnail

Study: Children Infected With Mild COVID-19 May Still Develop Long Symptoms

Pharmacy Times

Investigators from University of Texas Health Science Center at Houston analyze data from individuals aged 5 to 18 years enrolled in the Texas CARES survey.

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

GSK gets June 2023 FDA decision date for momelotinib

pharmaphorum

The clock is now ticking on the FDA’s review of GSK’s momelotinib for myelofibrosis patients with anaemia – the centrepiece of its $1.9 billion acquisition of Sierra Oncology which completed last month. The US regulator is due to make a decision on momelotinib by 16 June, 2023, on the basis of phase 3 results reported in January, said GSK.

FDA 105
article thumbnail

Pharmacy Focus: Technician Edition With NHA - Technician Perceptions of Patients With Opioid Use Disorder

Pharmacy Times

On the first episode, Jeremy Sasser and Jessica Langley-Loep, from the National Healthcareer Association, discuss pharmacy technician's perceptions of patients who may have opioid use disorder.

123
123

More Trending

article thumbnail

Study Results Show Leisure Activities May Help Lower Dementia Risk by up to 23%

Pharmacy Times

The meta-analysis reviews 38 available studies on the effects of cognitive, physical, and social activities on brain function.

132
132
article thumbnail

IN FOCUS: Northgate Technologies

Pharmaceutical Technology

RANKINGS 2022 Excellence Innovation Commended Excellence Product Launch Commended Excellence Safety Commended. The Verdict. Northgate Technologies Inc. (NTI) is a Illinois based producer of medical devices and technologies for the healthcare sector, with a particular focus on surgical environments. The company is ranked in the 2022 Excellence Rankings in the INNOVATION , PRODUCT LAUNCH and SAFETY categories.

98
article thumbnail

New Therapeutic Targets Could Treat Colon Tumors, Inflammatory Bowel Disease

Pharmacy Times

Scientists found that inhibiting certain immune system receptors could treat colon cancer and other diseases of the gastrointestinal tract.

article thumbnail

Inventing the COVID vax pill: a matter of convenience and durability

PharmaVoice

Recent data from Vaxart’s phase 1 trial of its COVID-19 inoculation pill shows potential.

130
130
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

With Cash Customers on the Rise, AI Could be Key to Pharmacy Pricing Profitability

Pharmacy Times

Does your pharmacy have the right technology in place to meet the ever-changing needs of your community and your business?

131
131
article thumbnail

Diving deeper into AI discovery, Sanofi signs 5-drug deal with Atomwise

pharmaphorum

Sanofi is tapping San Francisco-based Atomwise for a new AI-fuelled drug discovery deal, paying $20 million for five new drug targets — and possibly spending more than a billion in milestone payments and tiered royalties when all is said and done. The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop.

article thumbnail

C. difficile and C. difficile Infection (CDI) Overview and Risk Factors for CDI

Pharmacy Times

A gastroenterologist, Dr. Paul Feuerstadt, provides an overview of C. difficile infection (CDI) and vegetative and spore phases of CDI.

123
123
article thumbnail

Tackling the silent pandemic: AMR Industry Alliance sets the Standard

European Pharmaceutical Review

Antimicrobial resistance (AMR) is a growing concern worldwide. Recognised as one of the top 10 global health changes by the World Health Organization (WHO), 1 it was found to have played a role in 4.95 million deaths in 2019 and been the direct cause of 1.27 million of these, 2 meaning drug-resistant infections killed more people than HIV/AIDS (864,000 deaths) or malaria (643,000 deaths). 3 Just six resistant bacteria accounted for almost 80 percent of the direct deaths, with antibiotic-resistan

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Advances in Glioblastoma Multiforme Shift the Treatment Paradigm

Pharmacy Times

As local drug delivery technology evolves, the field is set for monumental change.

149
149
article thumbnail

Get Well takes digital approach to tackling monkeypox

pharmaphorum

With monkeypox now officially declared a public health emergency in the US, digital health company Get Well has developed a management plan to track people infected with monkeypox and help to deliver their care. The company says the digital monkeypox symptom monitoring tool takes the form of a 21-day care plan that educates patients about monkeypox and how it transmits, explains what symptoms look like, and gives advice on what they should do if they develop symptoms.

article thumbnail

Opioid Prescriptions for US Patients With Cancer, Non-Cancer Pain Falls, Study Results Show

Pharmacy Times

Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.

122
122
article thumbnail

WuXi STA breaks ground on new Delaware manufacturing facility

European Pharmaceutical Review

Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, US. The second facility for WuXi STA in the US, Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labelling, storage and distribution services for clinical trial materials and

article thumbnail

FDA Approves Generic Dexamethasone Tablets USP

Pharmacy Times

FDA approved dexamethasone tablets USP 1.5mg, 4mg and 6mg, providing a new generic alternative to the steroid Decadron.

FDA 123
article thumbnail

How to Make Sure Your Corporate Pharmaceutical ESG Strategy Is Appealing to Younger Generations

PharmExec

Environmental, social, and governance (ESG) standards are becoming more important for modern investors.

97
article thumbnail

Risk Factors for Primary and Recurrent C. difficile Infection (CDI)

Pharmacy Times

Drs Lodise and Feuerstadt discuss risk factors for C. difficile infection (CDI).

139
139
article thumbnail

Formulation development outsourcing market to be worth over $60bn by 2030

European Pharmaceutical Review

According to a recent report , the global formulation development outsourcing market size should grow to $61.4 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.2 percent from its 2022 value of $35.1 billion. The investigators found that the high burden of chronic and infectious diseases, growing focus on bioavailability enhancement for poorly soluble drugs, and the challenges associated with drug development were the major contributors to the demand for formulation develop

article thumbnail

FDA Approves Zynteglo for Patients with Beta-thalassemia Requiring Regular Blood Transfusions

Pharmacy Times

Zynteglo was approved for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions after safety and efficacy were demonstrated in clinical trials.

FDA 123
article thumbnail

US pharmacies ordered to pay $650.6m for role in opioids crisis

The Guardian - Pharmaceutical Industry

CVS, Walgreens and Walmart must pay damages to two Ohio counties for oversupplying pills that ended up on black market The US pharmacy chains CVS, Walmart and Walgreens must pay a combined $650.6m to two Ohio counties to address the damage done by the opioid epidemic, a federal judge ruled on Wednesday. The order by US judge Dan Polster in Cleveland comes after a jury last November concluded that the firms helped create a public nuisance in Lake and Trumbull counties by oversupplying addictive p

74
article thumbnail

FDA Approves Companion Diagnostic for Trastuzumab Deruxtecan in HER2-Mutated Non-Small Cell Lung Cancer

Pharmacy Times

The Oncomine Dx Target Test is a next-generation sequencing–based companion diagnostic developed to analyze 23 genes associated with non–small cell lung cancer in patients who harbor an activating HER2 mutation.

FDA 65
article thumbnail

UK life science competitiveness indicators 2022: measuring what matters most?

pharmaphorum

The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. The indicators did not bring universal good news , but Leela Barham argues we need to consider whether the indicators are measuring what matters most if we are to understand more about the health of the UK life sciences industry and, most importantly, what it means for patients.

59
article thumbnail

Sacituzumab Govitecan-hziy Significantly Improves Overall Survival in HR+/HER2- Metastatic Breast Cancer vs Chemotherapy

Pharmacy Times

Gilead Sciences Inc submitted a supplemental Biologics License Application to the FDA for sacituzumab govitecan-hziy (Trodelvy) following promising trial results.

article thumbnail

Respiratory Monitoring & AI Technologies

pharmaphorum

Returning for the 2nd annual year, the Biosensors for Medical Wearables Conference will be held in October 24 – 25 2022 in Boston, MA, USA. Delegates will have the chance to network and connect with the likes of: Pfizer, MedRhythms, Digital Medicine Society, AstraZeneca, CardioSignal, Neursantys, ActiGraph, PyrAmes, HexoSkin, TracPatch Health and many others.

59
article thumbnail

Tip of the Week: Consider How to Manage Implementation of Services

Pharmacy Times

Pharmacy managers manage the implementation of services, including ones commensurate with everyday practice as well as newer, more patient-centered services.

65
article thumbnail

Merck and Orna partner for RNA technology-based vaccines and therapies

Pharmaceutical Technology

Merck (MSD outside North America) has entered a partnership agreement with Orna Therapeutics for discovering, developing and marketing various programmes based on next-generation RNA technology. These programmes will include therapies and vaccines in infectious disease and oncology areas. By self-circularisation, Orna’s oRNA technology makes circular ribonucleic acids (oRNAs) from linear RNAs. oRNA molecules have been demonstrated to possess increased stability in vivo compared to linear mRNA an

article thumbnail

Cancer Deaths from Smoking Cigarettes Cause Billions in Lost Earnings

Pharmacy Times

A new study found that reduced tobacco use lowered deaths, person-years of lost life, and lost earnings across many states nationwide.

65
article thumbnail

How to Lead and Succeed in the Biosimilars Space

PharmExec

Key traits needed by leaders looking to grow their organizations in the biosimilars market.

83
article thumbnail

Reducing Dietary Sodium Is Key for Older Adults With Hypertension

Pharmacy Times

Advise restriction of the nutrient, along with intensive BP control, regimens promoting adherence, use of chlorthalidone in CKD.

65
article thumbnail

Health Equity: Clinical Development’s Future Framework

PharmExec

Thu, Aug 18, 2022 2:00 PM EDT Value for patients, value for all. Learn how today’s health equity initiatives are shaping best-in-class clinical development frameworks of the future.

52